Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapy

A. Krishan, S. W. Pitman, M. H N Tattersall, K. D. Paika, D. C. Smith, E. Frei

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

A rapid propidium iodide staining method was used for analysis of single cell suspensions of bone marrow and tumor biopsies by flow microfluorometry. With this technique, information on the proliferative status of target tissues can be obtained within 10 min of sample removal. DNA histograms and labeling index of sequential bone marrow biopsies from a patient with Stage IV diffuse lymphocytic leukemia and treated with 1 β D arabinofuranosylcytosine infusion showed pronounced reduction in the percentage of cycling cells. In contrast, sequential tumor biopsies from a melanoma patient on methotrexate citrovorum factor rescue therapy showed no changes. In sequential bone marrow biopsies of 3 patients on high dose methotrexate citrovorum factor rescue, initial accumulation of cells in G1 S (Day 1) was followed by a significant proliferative response (Days 4 to 7) and return to pretherapy values. In contrast, no recovery similar to that of the bone marrow was seen in tumor cells. The propidium iodide staining method for flow microfluorometry (FMF) analysis has been used in a variety of samples in clinical chemotherapy. The method is of particular usefulness for monitoring of bone marrow proliferation in patients on high dose MTX therapy followed by rescue with either citrovorum factor or thymidine. This paper illustrates the use of rapid FMF analysis in clinical chemotherapy.

Original languageEnglish
Pages (from-to)3813-3820
Number of pages8
JournalCancer Research
Volume36
Issue number10
StatePublished - Dec 1 1976
Externally publishedYes

Fingerprint

Bone Marrow Cells
Leucovorin
Bone Marrow
Biopsy
Drug Therapy
Flow Cytometry
Propidium
Methotrexate
Neoplasms
Single-Cell Analysis
Staining and Labeling
Lymphoid Leukemia
Cytarabine
Thymidine
Melanoma
Suspensions
DNA
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Krishan, A., Pitman, S. W., Tattersall, M. H. N., Paika, K. D., Smith, D. C., & Frei, E. (1976). Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapy. Cancer Research, 36(10), 3813-3820.

Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapy. / Krishan, A.; Pitman, S. W.; Tattersall, M. H N; Paika, K. D.; Smith, D. C.; Frei, E.

In: Cancer Research, Vol. 36, No. 10, 01.12.1976, p. 3813-3820.

Research output: Contribution to journalArticle

Krishan, A, Pitman, SW, Tattersall, MHN, Paika, KD, Smith, DC & Frei, E 1976, 'Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapy', Cancer Research, vol. 36, no. 10, pp. 3813-3820.
Krishan A, Pitman SW, Tattersall MHN, Paika KD, Smith DC, Frei E. Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapy. Cancer Research. 1976 Dec 1;36(10):3813-3820.
Krishan, A. ; Pitman, S. W. ; Tattersall, M. H N ; Paika, K. D. ; Smith, D. C. ; Frei, E. / Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapy. In: Cancer Research. 1976 ; Vol. 36, No. 10. pp. 3813-3820.
@article{6b7f2d736a5f4bc784734a313f2a9585,
title = "Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapy",
abstract = "A rapid propidium iodide staining method was used for analysis of single cell suspensions of bone marrow and tumor biopsies by flow microfluorometry. With this technique, information on the proliferative status of target tissues can be obtained within 10 min of sample removal. DNA histograms and labeling index of sequential bone marrow biopsies from a patient with Stage IV diffuse lymphocytic leukemia and treated with 1 β D arabinofuranosylcytosine infusion showed pronounced reduction in the percentage of cycling cells. In contrast, sequential tumor biopsies from a melanoma patient on methotrexate citrovorum factor rescue therapy showed no changes. In sequential bone marrow biopsies of 3 patients on high dose methotrexate citrovorum factor rescue, initial accumulation of cells in G1 S (Day 1) was followed by a significant proliferative response (Days 4 to 7) and return to pretherapy values. In contrast, no recovery similar to that of the bone marrow was seen in tumor cells. The propidium iodide staining method for flow microfluorometry (FMF) analysis has been used in a variety of samples in clinical chemotherapy. The method is of particular usefulness for monitoring of bone marrow proliferation in patients on high dose MTX therapy followed by rescue with either citrovorum factor or thymidine. This paper illustrates the use of rapid FMF analysis in clinical chemotherapy.",
author = "A. Krishan and Pitman, {S. W.} and Tattersall, {M. H N} and Paika, {K. D.} and Smith, {D. C.} and E. Frei",
year = "1976",
month = "12",
day = "1",
language = "English",
volume = "36",
pages = "3813--3820",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Flow microfluorometric patterns of human bone marrow and tumor cells in response to cancer chemotherapy

AU - Krishan, A.

AU - Pitman, S. W.

AU - Tattersall, M. H N

AU - Paika, K. D.

AU - Smith, D. C.

AU - Frei, E.

PY - 1976/12/1

Y1 - 1976/12/1

N2 - A rapid propidium iodide staining method was used for analysis of single cell suspensions of bone marrow and tumor biopsies by flow microfluorometry. With this technique, information on the proliferative status of target tissues can be obtained within 10 min of sample removal. DNA histograms and labeling index of sequential bone marrow biopsies from a patient with Stage IV diffuse lymphocytic leukemia and treated with 1 β D arabinofuranosylcytosine infusion showed pronounced reduction in the percentage of cycling cells. In contrast, sequential tumor biopsies from a melanoma patient on methotrexate citrovorum factor rescue therapy showed no changes. In sequential bone marrow biopsies of 3 patients on high dose methotrexate citrovorum factor rescue, initial accumulation of cells in G1 S (Day 1) was followed by a significant proliferative response (Days 4 to 7) and return to pretherapy values. In contrast, no recovery similar to that of the bone marrow was seen in tumor cells. The propidium iodide staining method for flow microfluorometry (FMF) analysis has been used in a variety of samples in clinical chemotherapy. The method is of particular usefulness for monitoring of bone marrow proliferation in patients on high dose MTX therapy followed by rescue with either citrovorum factor or thymidine. This paper illustrates the use of rapid FMF analysis in clinical chemotherapy.

AB - A rapid propidium iodide staining method was used for analysis of single cell suspensions of bone marrow and tumor biopsies by flow microfluorometry. With this technique, information on the proliferative status of target tissues can be obtained within 10 min of sample removal. DNA histograms and labeling index of sequential bone marrow biopsies from a patient with Stage IV diffuse lymphocytic leukemia and treated with 1 β D arabinofuranosylcytosine infusion showed pronounced reduction in the percentage of cycling cells. In contrast, sequential tumor biopsies from a melanoma patient on methotrexate citrovorum factor rescue therapy showed no changes. In sequential bone marrow biopsies of 3 patients on high dose methotrexate citrovorum factor rescue, initial accumulation of cells in G1 S (Day 1) was followed by a significant proliferative response (Days 4 to 7) and return to pretherapy values. In contrast, no recovery similar to that of the bone marrow was seen in tumor cells. The propidium iodide staining method for flow microfluorometry (FMF) analysis has been used in a variety of samples in clinical chemotherapy. The method is of particular usefulness for monitoring of bone marrow proliferation in patients on high dose MTX therapy followed by rescue with either citrovorum factor or thymidine. This paper illustrates the use of rapid FMF analysis in clinical chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=0017150145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017150145&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 3813

EP - 3820

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 10

ER -